Novo Nordisk Reports Impressive 13% Sales Growth in Q2 2025, Despite Lowered Full-Year Guidance

Novo Nordisk A/S reports a 13% increase in Q2 2025 sales to 76.9 billion Danish kroner, with net profit up by 32%. The company has lowered its full-year sales growth forecast due t...